U.S. Construction Stock News

An unexpected drop in the US Producer Price Index for August signaled cooling inflation and sharply lifted expectations for a Federal Reserve interest rate cut, with markets now pricing in a 90% chance of a quarter-point reduction at the next meeting. This shift in monetary policy outlook tends to support the industrial sector, as reduced borrowing costs can stimulate project development and greater demand for companies providing power resiliency solutions. We'll examine how the increased...

What Recent Leadership Changes Signal for Yum! Brands Stock If you are watching Yum! Brands (YUM) and wondering if now is the time to buy, the company’s latest C-suite shakeup definitely deserves your attention. This month, Yum! Brands announced Chris Turner will take over as CEO on October 1, capping a decades-long tenure for outgoing chief David Gibbs. Alongside Turner, Ranjith Roy is stepping into the CFO position, with Sean Tresvant and Jim Dausch elevated to new roles focused on consumer...

Hartford Insurance Group (HIG) just posted its latest quarterly results, and if you follow the stock, this one is hard to ignore. Core earnings clocked in at nearly $1 billion in the quarter, making a strong statement about the company’s ability to deliver operationally even when faced with challenging targets. True, revenues came in a bit below what analysts were looking for, but robust earnings suggest management is not just controlling costs. They are navigating headwinds more effectively...

Earlier this month, Upwork Inc. announced that its Board of Directors authorized a share repurchase program allowing the company to buy back up to US$100 million of its own stock, with no set expiration date. This share buyback gives Upwork flexibility to manage its capital structure and may reflect management’s belief in the company’s long-term value. In light of Upwork’s newly announced US$100 million share repurchase plan, we’ll explore how this capital allocation could influence the...

Argus downgraded J.M. Smucker (NYSE:SJM) from Buy to Hold, citing challenges including slowing volume growth, ongoing economic uncertainty, commodity inflation, and supply-chain pressures, particularly as rising green coffee prices and tariffs strain margins despite company efforts around price increases and productivity. J.M. Smucker’s recent acquisition of Hostess Brands signals a push to expand within the convenience food market while seeking cross-promotional opportunities and broader...

Symbotic was recently named one of Fast Company’s 2025 Best Workplaces for Innovators, recognizing its leadership in fostering innovation under CEO Rick Cohen and its robust portfolio of over 1,050 AI and robotics patents worldwide. This accolade comes as the company continues to advance AI-driven supply chain technologies and attract attention following a recent quarterly earnings miss paired with forecasts of a turnaround to profitability this fiscal year. We’ll explore how Symbotic’s...

If you have ever owned WNS (Holdings) or followed it from the sidelines, you are already familiar with the rollercoaster that is its stock price. Lately, the ride has tilted more upward than not. Shares closed most recently at $75.63, steadily rising with a 59.9% jump so far this year and 31.5% over the past twelve months. That is a dramatic level of outperformance that has attracted plenty of new fans and a few skeptics questioning whether the best gains are now behind us. Shorter-term gains...

Earlier this month, Genuine Parts Company announced the appointment of Courtney Carruthers, former President and CEO of TricorBraun, and Matt Carey, former Executive Vice President and Chief Information Officer at The Home Depot, to its Board of Directors as independent directors, while two long-serving board members retired. This board refresh introduces expertise in digital transformation, cybersecurity, and global distribution, reflecting the company's intent to align leadership skills...

Rockwell Automation (ROK) is back in the spotlight following a fresh wave of scrutiny over its capital allocation strategy. Investors are weighing the impacts of management’s decision to ramp up reinvestment, especially as recent analysis points to a steady decline in return on capital employed over the past five years. While it is worth noting that returns still outpace the industry, the trend, combined with the news that a top executive recently sold a substantial number of shares,...

Sprinklr recently reported its second quarter results, showing year-over-year growth in revenue to US$212.04 million and net income of US$12.62 million, and announced the upcoming departure of CFO Manish Sarin later this month. Along with a leadership shakeup and new earnings guidance, the company completed a significant share buyback, repurchasing over 17.6 million shares for US$150.05 million. We'll examine how the CFO transition and recent earnings results may influence Sprinklr's...

Celldex Therapeutics (CLDX) has attracted attention recently after announcing encouraging results from its Phase 2 trial for barzolvolimab. The therapy showed successful mast cell depletion in eosinophilic esophagitis and delivered positive outcomes for chronic spontaneous urticaria, two areas where new treatment options are in demand. Although the therapy did not yield symptom improvement in eosinophilic esophagitis, the study’s biological results have sparked renewed interest among...

Luckin Coffee (OTCPK:LKNC.Y) is making headlines after opening its flagship store in New York City, a major milestone that places the Chinese coffee giant right in the hometown of global rivals. For investors, this is more than just another international launch. It signals a bold play to capture US market share and compete directly with established American brands. With the buzz around this move, everyone is asking what it means for the stock. The excitement from expanding stateside appears...

Hims & Hers Health, Inc. recently announced an exclusive partnership with Marius Pharmaceuticals to expand into the men's health market by offering innovative, affordable, and personalized low testosterone treatment plans, including the FDA-approved oral testosterone KYZATREX® and at-home blood testing starting in 2026. This move positions Hims & Hers to address an estimated 20 million men in the US affected by low testosterone, diversifying its offerings well beyond its core sexual health...

If you have been following Fox Factory Holding (FOXF), you might have noticed something interesting brewing recently. During the first quarter, several prominent institutional investors stepped up their positions in the company, with some significantly boosting their stakes. Meanwhile, Wall Street’s upbeat outlook, with analysts maintaining buy ratings and raising their expectations, signals a growing sense of confidence in Fox Factory’s future that is beginning to ripple through the broader...

In August 2025, AllianceBernstein reported a 2% increase in assets under management to US$844 billion, citing positive firmwide net inflows and market appreciation, with gains in the Institutional and Private Wealth channels offsetting outflows in Retail. This growth across multiple asset classes and client segments highlights the company's effective distribution strategy and operational resilience amid varying investor preferences. We’ll explore how continued net inflows and asset growth...

On June 20, 2025, KBR announced that the U.S. Transportation Command had terminated HomeSafe Alliance's involvement in the Global Household Goods Contract, which has prompted a law firm investigation into whether the company issued misleading business information. This development raises significant concerns about KBR's exposure to legal and financial risks tied to major government contracts and associated disclosures. We'll look at how the potential for securities litigation following a...

Textron (TXT) has been attracting the attention of value-minded investors following a wave of recent analyst reports highlighting the company’s appealing valuation. Industry watchers have pointed to Textron’s favorable P/E and PEG ratios, as well as a strong earnings outlook, sparking optimism about whether the market may be underestimating the company’s prospects. This renewed focus coincides with Textron’s recent appearance at a major industry conference, bringing the story into clearer...

Thinking about what to do with Manchester United stock? You are definitely not alone. After a modest pop of 3.3% over the past week, some traders see signs of life, while others point to a more sobering 7.8% drop over the last month. Year-to-date, Man United shares are down 3.4%, with a gentle 1.0% uptick over the past year, and a 16.0% gain if you have been holding since three years ago. It has been a bit of a mixed bag. This is certainly nothing like the surging sport valuations that have...

In the past week, Kontoor Brands received a series of positive analyst outlooks from major research firms, including Wells Fargo, UBS, and Barclays, reflecting increased confidence in the company's growth prospects. This coordinated reassessment by respected analysts underscores broader optimism about Kontoor Brands' ability to execute on key growth drivers and respond effectively to evolving market expectations. With leading analysts now highlighting a strengthened outlook, we'll examine...

Earlier in September 2025, Zillow Group introduced Virtual Staging, an AI-powered feature now available within its premium listing platform, Showcase, which allows home shoppers to interactively restyle rooms with various design options and view immersive property imagery. This marks the first major integration of technology acquired through Zillow's 2024 purchase of Virtual Staging AI, signaling a broader shift toward seamlessly embedding advanced AI into consumer real estate experiences to...

If you are reevaluating your position in Madrigal Pharmaceuticals (MDGL) after its latest quarterly update, you are not alone. The company surprised markets by reporting stronger-than-expected second-quarter sales, driven by its flagship liver disease drug Rezdiffra. Over 23,000 patients are already using the treatment, and the recent European Union approval appears to have reinforced Madrigal’s reputation as a front-runner in the MASH therapy market. Momentum has been clearly building for...

Between 2022 and 2024, Roku increased its active user base from 70 million to 90 million, kept hardware and service prices steady despite inflation, and expanded its sports content offerings, while maintaining financial momentum and drawing continued market attention. An interesting insight is that Roku’s patient approach to pricing during the inflation period and its push into high-engagement sports programming have started to deliver tangible financial and operational benefits, setting it...

Willis Towers Watson (WTW) has been making headlines, prompting investors to take a closer look. In a dual development, the company announced a global technology partnership with Sompo Holdings to roll out its Radar software group-wide, marking a milestone as its first such deal in Japan. In addition, WTW welcomed two senior leaders from rivals Marsh and Canopius to its Placement and Portfolio Solutions team. For anyone considering what to do with WTW shares, these steps may signal more than...

D.R. Horton recently experienced a decline in analyst sentiment as ongoing industry headwinds, including elevated mortgage rates, rising construction costs, and labor shortages, heightened concerns ahead of its expected October 2025 earnings report, which analysts forecast will show year-over-year declines in earnings and revenue. The company is addressing these pressures by leveraging cost controls, operational improvements, and technology adoption, which could help support its competitive...